Wei‐Yin Wu

611 total citations
24 papers, 452 citations indexed

About

Wei‐Yin Wu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Wei‐Yin Wu has authored 24 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in Wei‐Yin Wu's work include Sirtuins and Resveratrol in Medicine (3 papers), MicroRNA in disease regulation (3 papers) and Ion channel regulation and function (3 papers). Wei‐Yin Wu is often cited by papers focused on Sirtuins and Resveratrol in Medicine (3 papers), MicroRNA in disease regulation (3 papers) and Ion channel regulation and function (3 papers). Wei‐Yin Wu collaborates with scholars based in China, Canada and Hong Kong. Wei‐Yin Wu's co-authors include Gang� Li, Yi‐Xiang Hong, Gui‐Rong Li, Chan Wu, Yun‐Da Li, Fei Song, Wu Yao, Yan Wang, Weimin Han and Yan Wang and has published in prestigious journals such as Journal of the American College of Cardiology, British Journal of Pharmacology and Frontiers in Microbiology.

In The Last Decade

Wei‐Yin Wu

24 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Yin Wu China 13 241 103 58 56 55 24 452
Xiaoyang Huang China 11 203 0.8× 75 0.7× 55 0.9× 47 0.8× 70 1.3× 14 388
V. Vijaya Padma India 14 233 1.0× 91 0.9× 77 1.3× 53 0.9× 23 0.4× 21 478
Chan Wu China 11 219 0.9× 81 0.8× 48 0.8× 47 0.8× 41 0.7× 27 513
Shengban You China 7 195 0.8× 79 0.8× 40 0.7× 39 0.7× 31 0.6× 8 413
Ya‐Ge Jin China 15 306 1.3× 176 1.7× 65 1.1× 92 1.6× 25 0.5× 18 613
Himangshu Sonowal United States 14 273 1.1× 59 0.6× 52 0.9× 45 0.8× 18 0.3× 20 537

Countries citing papers authored by Wei‐Yin Wu

Since Specialization
Citations

This map shows the geographic impact of Wei‐Yin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Yin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Yin Wu more than expected).

Fields of papers citing papers by Wei‐Yin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Yin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Yin Wu. The network helps show where Wei‐Yin Wu may publish in the future.

Co-authorship network of co-authors of Wei‐Yin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Yin Wu. A scholar is included among the top collaborators of Wei‐Yin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Yin Wu. Wei‐Yin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Chan, et al.. (2024). Pyroptosis and mitochondrial function participated in miR-654-3p-protected against myocardial infarction. Cell Death and Disease. 15(6). 393–393. 6 indexed citations
2.
Hong, Yi‐Xiang, Chan Wu, Fei Song, et al.. (2024). SUMOylation of TP53INP1 is involved in miR-30a-5p-regulated heart senescence. Experimental & Molecular Medicine. 56(11). 2519–2534. 4 indexed citations
3.
Wang, Ruiying, Chan Wu, Wei‐Yin Wu, et al.. (2024). The gut microbiotas with metabolites regulate the protective role of miR-30a-5p in myocardial infarction. Journal of Advanced Research. 75. 473–489. 2 indexed citations
4.
Liu, Binghong, Fei Song, Xiaoxia Zhou, et al.. (2024). NEDD4L is a promoter for angiogenesis and cell proliferation in human umbilical vein endothelial cells. Journal of Cellular and Molecular Medicine. 28(8). 1–11. 7 indexed citations
5.
Song, Fei, Yu Hu, Shanshan Zhao, et al.. (2022). Acacetin attenuates diabetes-induced cardiomyopathy by inhibiting oxidative stress and energy metabolism via PPAR-α/AMPK pathway. European Journal of Pharmacology. 922. 174916–174916. 30 indexed citations
6.
Wei, Ming, Wei‐Yin Wu, Yancun Zhao, et al.. (2022). The Xanthomonas citri Reverse Fitness Deficiency by Activating a Novel β-Glucosidase Under Low Osmostress. Frontiers in Microbiology. 13. 887967–887967. 1 indexed citations
7.
Hong, Yi‐Xiang, Wei‐Yin Wu, Weimin Han, et al.. (2022). Acacetin ameliorates cardiac hypertrophy by activating Sirt1/AMPK/PGC-1α pathway. European Journal of Pharmacology. 920. 174858–174858. 34 indexed citations
8.
Wu, Wei‐Yin, et al.. (2022). An overview of PAX1: Expression, function and regulation in development and diseases. Frontiers in Cell and Developmental Biology. 10. 1051102–1051102. 12 indexed citations
9.
Wu, Chan, et al.. (2022). Acacetin alleviates myocardial ischaemia/reperfusion injury by inhibiting oxidative stress and apoptosis via the Nrf-2/HO-1 pathway. Pharmaceutical Biology. 60(1). 553–561. 29 indexed citations
10.
Song, Fei, et al.. (2021). Ubiquitinated ligation protein NEDD4L participates in MiR-30a-5p attenuated atherosclerosis by regulating macrophage polarization and lipid metabolism. Molecular Therapy — Nucleic Acids. 26. 1303–1317. 25 indexed citations
11.
Yao, Wu, Fei Song, Yun‐Da Li, et al.. (2020). Acacetin exerts antioxidant potential against atherosclerosis through Nrf2 pathway in apoE −/− Mice. Journal of Cellular and Molecular Medicine. 25(1). 521–534. 47 indexed citations
12.
Wu, Wei‐Yin, Yi‐Xiang Hong, Yun‐Da Li, et al.. (2020). Doxorubicin cardiomyopathy is ameliorated by acacetin via Sirt1‐mediated activation of AMPK/Nrf2 signal molecules. Journal of Cellular and Molecular Medicine. 24(20). 12141–12153. 47 indexed citations
13.
Zhang, Kai, Wei‐Yin Wu, Gang� Li, et al.. (2019). Regulation of the TRPC1 channel by endothelin-1 in human atrial myocytes. Heart Rhythm. 16(10). 1575–1583. 4 indexed citations
14.
Zhang, Rui, Wei‐Yin Wu, Zhiquan Wang, et al.. (2019). Comparative study of carvedilol and quinidine for inhibiting hKv4.3 channel stably expressed in HEK 293 cells. European Journal of Pharmacology. 853. 74–83. 7 indexed citations
15.
Wu, Wei‐Yin, Yun‐Da Li, Chan Wu, et al.. (2018). The Natural Flavone Acacetin Confers Cardiomyocyte Protection Against Hypoxia/Reoxygenation Injury via AMPK-Mediated Activation of Nrf2 Signaling Pathway. Frontiers in Pharmacology. 9. 497–497. 62 indexed citations
16.
Li, Gang�, Ying Song, Yun‐Da Li, et al.. (2018). GW29-e1500 Circulating miRNA-302 family members as potential biomarkers for the diagnosis of acute heart failure. Journal of the American College of Cardiology. 72(16). C73–C74. 1 indexed citations
17.
Wu, Wei‐Yin, Yun‐Da Li, Yi‐Xiang Hong, et al.. (2018). GW29-e0611 Acacetin inhibits doxorubicin–induced cardiotoxicity by activating Sirt1/AMPK/Nrf2 pathway. Journal of the American College of Cardiology. 72(16). C70–C71. 2 indexed citations
18.
Li, Gang�, Hui Che, Wei‐Yin Wu, et al.. (2018). Bradykinin‐mediated Ca2+ signalling regulates cell growth and mobility in human cardiac c‐Kit+ progenitor cells. Journal of Cellular and Molecular Medicine. 22(10). 4688–4699. 9 indexed citations
19.
Wu, Wei‐Yin, et al.. (2016). Clemizole hydrochloride blocks cardiac potassium currents stably expressed in HEK 293 cells. British Journal of Pharmacology. 174(3). 254–266. 12 indexed citations
20.
Chang, He, Yan Wang, Wei‐Yin Wu, et al.. (2013). Hydrodynamics-based delivery of an interleukin-1 receptor II fusion gene ameliorates rat autoimmune myocarditis by inhibiting IL-1 and Th17 cell polarization. International Journal of Molecular Medicine. 31(4). 833–840. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoyang Huang Breakdown of academic impact, for papers by V. Vijaya Padma Breakdown of academic impact, for papers by Chan Wu Breakdown of academic impact, for papers by Shengban You Breakdown of academic impact, for papers by Ya‐Ge Jin Breakdown of academic impact, for papers by Himangshu Sonowal
Rankless by CCL
2026